Genetic predisposition, colonoscopy findings may help clarify CRC screening intervals

Patients with a genetic predisposition for colorectal cancer could help define risk-adapted surveillance intervals after detection and removal of adenomas at colonoscopy, according to a study in Clinical Gastroenterology and Hepatology.“Previous studies have suggested that polygenic risk scores (PRSs) could help define personalized colorectal cancer for screening strategies, such as starting ages for screening and rescreening intervals after colonoscopy with normal findings,” Feng Guo, PhD, MSc, of the division of clinical epidemiology and aging research at the German CancerRead More

Related Articles